Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 5, 2008, Pages 1033-1039

  Ergani Ozcan, Ayla ^a   Naas, Thierry ^b   Baysan, Betil Ozhak ^a   Ogunc, Dilara ^a   Inan, Dilara ^a   Colak, Dilek ^a   Nordmann, Patrice ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b BICÊTRE HOSPITAL   (France)

Author keywords

MLST; Tn1546; vanA; VRE

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; CYTOLYSIN; ERYTHROMYCIN; FOSFOMYCIN; GELATINASE; GENTAMICIN; GLYCOPEPTIDE; HYALURONIDASE; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; LINEZOLID; MEMBRANE PROTEIN; NITROFURANTOIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PRISTINAMYCIN; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

3' UNTRANSLATED REGION; ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISINFECTION; ENTEROCOCCUS FAECIUM; ENVIRONMENTAL SANITATION; EPIDEMIC; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PATIENT CARE; PEDIATRIC WARD; POLYMERASE CHAIN REACTION; SEPSIS; STRAIN DIFFERENCE; TRANSPOSON; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL UNITS; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; TURKEY; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 42149136755     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn066     Document Type: Article

References (38)

1. Murray BE. Vancomycin-resistant enterococcal infections. N Eng J Med 2000; 342: 710.
2. Uttley AH, Collins CH, Naidoo J et al. Vancomycin-resistant enterococci. Lancet 1988; 1: 57-8.
3. Leclercq R, Derlot E, Duval J et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Eng J Med 1988; 319: 157-61.
4. Woodford N. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. Microb Drug Resist 2001; 7: 229-34.
5. Leavis HL, Bonten MJ, Willems RJ. Identification of high-risk enterococcal clonal complexes: Global dispersion and antibiotic resistance. Curr Opin Microbiol 2006; 9: 454-60.
6. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13: 686-707.
7. Schouten MA, Hoogkamp-Korstanje JA, Meis JF et al. Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 2000; 19: 816-22.
8. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993; 37 1563-71.
9. Palepou MI, Adebiyi AA,Tremlett CH et al. Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci. J Antimicrob Chemother 1998; 42: 605-12.
10. Poyart C, Trieu-Cuot P. Heterogeneric conjugal transfer of the pheromone-responsive plasmid plP964 (IncHlyl) of Enterococcus faecalis in the apparent absence of pheromone induction. FEMS Microbiol Lett 1994; 112: 173-9.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
12. Top J, Schouls LM, Bonten MJM et al. Multiple-locus variable-number tandem repeat analysis, a novel typing scheme to study the genetic relatedness and epidemiology of Enterococcus faecium isolates. J Clin Microbiol 2004; 42: 4503-11.
13. Homan WL, Tribe D, Poznanski S et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 2002; 40: 1963-71.
14. Kühn I, Burman LG, Haeggman S et al. Biochemical fingerprinting compared with ribotyping and pulsed-field gel electrophoresis of DNA for epidemiological typing of enterococci. J Clin Microbiol 1995; 33: 2812-7.
15. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 24-7.
16. Tenover FC, Arbeit R, Goering V et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33 2233-9.
17. Basustaoglu A, Aydogan H, Beyan C et al. First glycopeptide-resistant Enterococcus faecium isolate from blood culture in Ankara, Turkey. Emerg Infect Dis 2001; 7: 160-1.
18. Çolak D, Naas T, Gunseren F et al. First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey. J Antimicrob Chemother 2002; 50: 397-401.
19. Siegel JD, Rhinehart E, Jackson M et al. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007; 35 Suppl 2: S165-93.
20. Naas T, Fortineau N, Snanoudj R et al. First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype. J Clin Microbiol 2005; 43: 3642-9.
21. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
22. Tremlett CH, Brown DF, Woodford N. Variation in structure and location of VanA glycopeptide resistance elements among enterococci from a single patient. J Clin Microbiol 1999; 37: 818-20.
23. Kieser T. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 1984; 12 19-36.
24. Danel F, Hall MC, Gur D et al. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995; 39: 1881-4.
25. Miele A, Bandera M, Goldstein BP. Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob Agents Chemother 1995; 39: 1772-8.
26. Willems RJ, Top J, Van den Braak N et al. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother 1999; 43 483-91.
27. Vankerckhoven V, Van Autgaerden T, Vael C et al. Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol 2004; 42: 4473-9.
28. Comert FB, Kulah C, Aktas E et al. First isolation of vancomycin-resistant enterococci and spread of a single clone in a university hospital in northwestern Turkey. Eur J Clin Microbiol Infect Dis 2007; 26: 57-61.
29. Willems RJ, Top J, van Santen M et al. Global spread of vancomycin-resistant Enterococcus faecium from disfinct nosocomial genetic complex. Emerg Infect Dis 2005; 11: 821-8.
30. Klare I, Konstabel C, Mueller-Bertling S et al. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis 2005; 24: 815-25.
31. Leavis H, Top J, Shankar N et al. A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J Bacteriol 2004; 186: 672-82.
32. Hayden MK. Insights into the epidemiology and control ol infection with vancomycin-resistant enterococci. Clin infect Dis 2000; 31: 1058-65.
33. Kim WJ, Weinstein RA, Hayden MK. The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 7-year period. J Infect Dis 1999; 179: 163-71.
34. Song JH, Ko KS, Oh WS et al. High frequency of vancomycin-resistant Enterococcus faecium isolates with VanB phenotype and vanA genotype in Korean hospitals. Diagn Microbiol Infect Dis 2006; 56: 401-6.
35. Lee WG, Huh JY, Cho SR et al. Reduction in glycopeptide resistance in vancomycin-resistant enterococci as a result of vanA cluster rearrangements. Antimicrob Agents Chemother 2004; 48: 1379-81.
36. Eom JS, Hwang IS, Hwang BY et al. Emergence of vanA geno-type vancomycin-resistant enterococci with low or moderate levels of teicoplanin resistance in Korea. J Clin Microbiol 2004; 42 1785-6.
37. Hashimoto Y, Tanimoto K, Ozawa Y et al. Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistance. FEMS Microbiol Lett 2000; 185: 247-54.
38. Huh JY, Lee WG, Lee K et al. Distribution of insertion sequences associated with Tn1546-like elements among Enterococcus faecium isolates from patients in Korea. J Clin Microbiol 2004; 42 1897-902.